51 Biggest Movers From Yesterday

Gainers

  • Pyxus International Inc PYX shares climbed 26.9% to close at $17.04 on Tuesday after Imperial Capital initiated coverage on the stock with an Outperform rating and announced a $71 price target.
  • Allergan plc AGN shares gained 25.4% to close at $162.43 on Tuesday after AbbVie Inc ABBV announced plans To acquire Allergan for $188.24 per share in cash and stock.
  • Syros Pharmaceuticals, Inc. SYRS rose 16.4% to close at $7.52.
  • Xencor Inc XNCR climbed 13.9% to close at $38.56 after it was announced the company would replace HFF Inc in the S&P SmallCap 600.
  • Atossa Genetics Inc. ATOS gained 13.8% to close at $2.31.
  • SilverSun Technologies, Inc. SSNT shares climbed 13.4% to close at $2.79.
  • Pier 1 Imports, Inc. PIR gained 12.8% to close at $8.66 on Tuesday after falling 32.2% on Monday.
  • Xenetic Biosciences, Inc. XBIO rose 12.3% to close at $9.16.
  • Mesoblast Limited MESO rose 11.8% to close at $5.60.
  • Capital Senior Living Corporation CSU surged 11.7% to close at $4.86.
  • Replimune Group, Inc. REPL surged 11.7% to close at $14.31.
  • ARCA biopharma, Inc. ABIO gained 11.2% to close at $7.42.
  • Arbutus Biopharma Corporation ABUS jumped 11% to close at $2.42.
  • Rafael Holdings, Inc. RFL rose 10.6% to close at $26.54. Rafael Pharmaceuticals entered into an out-licensing agreement with Ono Pharmaceutical to accelerate clinical development and commercialization of cancer drug candidate CPI-613 in Japan and other Asian countries.
  • Dova Pharmaceuticals, Inc. DOVA gained 9.6% to close at $10.25 after the company announced European Union Marketing authorization for DOPTELET for the treatment of thrombocytopenia in patients with chronic liver disease.
  • Riot Blockchain, Inc. RIOT shares rose 8.6% to close at $3.3000 after climbing 10.55% on Monday.
  • Hemispherx Biopharma, Inc. HEB shares jumped 8.5% to close at $4.3200.
  • ArQule, Inc. ARQL rose 8.1% to close at $10.82. ArQule priced 9.25 million share offering at $9.75 per share.
  • USANA Health Sciences, Inc. USNA gained 7.6% to close at $77.82. USANA Health Sciences will replace Fidelity Southern in the S&P SmallCap 600 on Monday, July 1.
  • Biopharmx Corp BPMX shares fell 7.4% to close at $0.8200 after the company announced that its Phase 2b trial of BPX-04 for Populopustular Rosacea met both primary and secondary endpoints and was well tolerated.
  • Rubius Therapeutics, Inc. RUBY jumped 6.5% to close at $14.60.
  • Mesa Laboratories, Inc. MLAB shares rose 5.5% to close at $238.60. Mesa Laboratories will replace Axon Enterprise in the S&P SmallCap 600 on Monday, July 1.
  • Grubhub Inc. GRUB rose 5.1% to close at $75.90. Citigroup upgraded GrubHub from Neutral to Buy.
  • Acasti Pharma Inc. ACST gained 4% to close at $1.05 following a bullish Seeking Alpha blog post that mentioned potential valuation around $55 per share.

 


Losers

  • Acer Therapeutics Inc ACER shares dipped 78.6% to close at $4.12 on Tuesday after the FDA rejected its New Drug Application for EDSIVO.
  • Conatus Pharmaceuticals Inc CNAT dropped 68.5% to close at $0.2901 after reporting that top-line results from the ENCORE-LF trial of emricasan did not meet the primary endpoint and will discontinue further treatment of patients enrolled.
  • Gamida Cell Ltd GMDA fell 30.9% to close at $4.9800. Gamida Cell announced the launch of a proposed follow-on public offering of about $30 million worth of its shares.
  • Cemtrex, Inc. CETX dropped 29.6% to close at $2.3100. Cemtrex completed the development of augmented reality application for National Cultural Center in Saudi Arabia.
  • VivoPower International PLC VVPR shares declined 27.3% to close at $1.4900.
  • Immunic, Inc. IMUX fell 25.6% to close at $13.20 after rising 90.86% on Monday.
  • India Globalization Capital, Inc. IGC shares fell 18.1% to close at $1.68.
  • comScore, Inc. SCOR dropped 18% to close at $6.10.
  • Gravity Co., Ltd. GRVY dropped 17.3% to close at $45.00.
  • CEL-SCI Corporation CVM fell 17.1% to close at $7.19.
  • Basic Energy Services, Inc. BAS dipped 16.5% to close at $2.03 after Piper Jaffray downgraded the stock from Overweight to Neutral.
  • AbbVie Inc. ABBV fell 16.3% to close at $65.70 after the company announced it will acquire Allergan for $188.24 per share.
  • China Internet Nationwide Financial Services Inc. CIFS dropped 12.8% to close at $1.97.
  • Golden Bull Limited DNJR shares slipped 12.5% to close at $3.2300.
  • Aldeyra Therapeutics, Inc. ALDX dropped 12.4% to close at $6.21. Aldeyra, which focuses on therapies for immune-mediated diseases, reported its Phase 3 trial dubbed SOLACE that evaluated its reproxalap, code-named ADX-102 (a topical ophthalmic solution) in non-infectious anterior uveitis did not meet both the primary and secondary endpoints.
  • Uniti Group Inc. UNIT dropped 12.3% to close at $9.38. Uniti reported the launch of exchangeable notes offering and extension of revolving credit facility.
  • Epizyme, Inc. EPZM fell 12.1% to close at $13.29.
  • Brighthouse Financial, Inc. BHF shares fell 11.7% to close at $33.66. Credit Suisse downgraded Brighthouse Financial from Neutral to Underperform and lowered the price target from $35 to $22, while Goldman Sachs downgraded the stock from Neutral to Sell and lowered the price target from $39 to $32.
  • Amtech Systems, Inc. ASYS fell 11.6% to close at $5.10.
  • Zynex, Inc. ZYXI dropped 10.5% to close at $10.50.
  • Coda Octopus Group, Inc. CODA dipped 10.4% to close at $12.98.
  • Evofem Biosciences, Inc. EVFM tumbled 9.8% to close at $6.02.
  • Forterra, Inc. FRTA shares fell 9.4% to close at $4.1300. Forterra named Karl Watson as CEO and reaffirmed its FY19 outlook.
  • Seres Therapeutics, Inc. MCRB fell 7% to close at $2.79.
  • Minerva Neurosciences, Inc. NERV fell 6.1% to close at $5.57 after surging 40.19% on Monday.
  • The Medicines Company MDCO fell 4.5% to close at $33.76 after reporting a $150 million common stock offering.
  • Pivotal Software, Inc. PVTL fell 4.1% to close at $10.89. Bank of America downgraded Pivotal Software from Neutral to Underperform and lowered the price target from $16 to $12.

Posted In: LosersMovers From TuesdayMovers From YesterdayTop GainersYesterday's GainersNewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.